Amanda Smith - Publications

University of Pittsburgh, Pittsburgh, PA, United States 

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Cohen AD, Zigmond MJ, Smith AD. Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: time course of protection and neurorestoration. Brain Research. 1370: 80-8. PMID 21062624 DOI: 10.1016/J.Brainres.2010.11.006  0.6
2010 Leak RK, Castro SL, Jaumotte JD, Smith AD, Zigmond MJ. Assaying multiple biochemical variables from the same tissue sample. Journal of Neuroscience Methods. 191: 234-8. PMID 20600314 DOI: 10.1016/j.jneumeth.2010.06.023  0.6
2009 Zigmond MJ, Cameron JL, Leak RK, Mirnics K, Russell VA, Smeyne RJ, Smith AD. Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency. Parkinsonism & Related Disorders. 15: S42-5. PMID 20083005 DOI: 10.1016/S1353-8020(09)70778-3  0.6
2009 Gilpin NW, Smith AD, Cole M, Weiss F, Koob GF, Richardson HN. Operant behavior and alcohol levels in blood and brain of alcohol-dependent rats. Alcoholism, Clinical and Experimental Research. 33: 2113-23. PMID 19740131 DOI: 10.1111/J.1530-0277.2009.01051.X  0.6
2009 Wang J, Lou H, Pedersen CJ, Smith AD, Perez RG. 14-3-3zeta contributes to tyrosine hydroxylase activity in MN9D cells: localization of dopamine regulatory proteins to mitochondria. The Journal of Biological Chemistry. 284: 14011-9. PMID 19289463 DOI: 10.1074/jbc.M901310200  0.6
2008 Lindgren N, Leak RK, Carlson KM, Smith AD, Zigmond MJ. Activation of the extracellular signal-regulated kinases 1 and 2 by glial cell line-derived neurotrophic factor and its relation to neuroprotection in a mouse model of Parkinson's disease. Journal of Neuroscience Research. 86: 2039-49. PMID 18438911 DOI: 10.1002/jnr.21641  0.6
2007 Venneti S, Lopresti BJ, Wang G, Slagel SL, Mason NS, Mathis CA, Fischer ML, Larsen NJ, Mortimer AD, Hastings TG, Smith AD, Zigmond MJ, Suhara T, Higuchi M, Wiley CA. A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation. Journal of Neurochemistry. 102: 2118-31. PMID 17555551 DOI: 10.1111/J.1471-4159.2007.04690.X  0.6
2005 Liang Q, Smith AD, Pan S, Tyurin VA, Kagan VE, Hastings TG, Schor NF. Neuroprotective effects of TEMPOL in central and peripheral nervous system models of Parkinson's disease Biochemical Pharmacology. 70: 1371-1381. PMID 16144694 DOI: 10.1016/j.bcp.2005.04.011  0.6
2005 Smith AD, Kozlowski DA, Bohn MC, Zigmond MJ. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats. Experimental Neurology. 193: 420-6. PMID 15869944 DOI: 10.1016/J.Expneurol.2005.01.010  0.6
2003 Smith AD, Zigmond MJ. Can the brain be protected through exercise? Lessons from an animal model of parkinsonism. Experimental Neurology. 184: 31-9. PMID 14637076 DOI: 10.1016/j.expneurol.2003.08.017  0.6
2003 Smith AD, Antion M, Zigmond MJ, Austin MC. Effect of 6-hydroxydopamine on striatal GDNF and nigral GFRalpha1 and RET mRNAs in the adult rat. Brain Research. Molecular Brain Research. 117: 129-38. PMID 14559146 DOI: 10.1016/S0169-328X(03)00289-4  0.6
2003 Cohen AD, Tillerson JL, Smith AD, Schallert T, Zigmond MJ. Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. Journal of Neurochemistry. 85: 299-305. PMID 12675906 DOI: 10.1046/J.1471-4159.2003.01657.X  0.6
2002 Smith AD, Castro SL, Zigmond MJ. Stress-induced Parkinson's disease: a working hypothesis. Physiology & Behavior. 77: 527-31. PMID 12526994 DOI: 10.1016/S0031-9384(02)00939-3  0.6
2000 Smith AD, Smith DL, Zigmond MJ, Amalric M, Koob GF. Differential effects of dopamine receptor subtype blockade on performance of rats in a reaction-time paradigm. Psychopharmacology. 148: 355-60. PMID 10928307 DOI: 10.1007/s002130050063  0.6
Show low-probability matches.